The effect of deep eutectic solvent on the pharmacokinetics of salvianolic acid B in rats and its acute toxicity test

Deep eutectic solvent (DES), the benign green solvent with uniquely physical properties, has been widely applied in various fields. Our previous study indicated that DES could improve the stability and extraction efficiency of salvianolic acid B (SAB). In this work, with SAB as a model drug, the feasibility of DES as a drug carrier for oral preparation was investigated by evaluating the influence of DES on the pharmacokinetics of SAB and the toxicity of DES. Acute oral toxicity test illustrated that choline chloride-glycerol (ChCl-GL, molar ratio 1:2) was non-toxic with the median lethal dose of 7733 mg/kg. To comparison the difference of pharmacokinetics between SAB dissolved in ChCl-GL (1:2) and in water, a rapid and sensitive ultra-performance liquid chromatography coupled with mass spectrum was established to determine SAB and its metabolites in rat plasma. The method validation was also tested for the specificity, linearity (r(2) > 0.9980 over two orders of magnitude), precision (intro-day relative standard deviation (RSD) < 2.73% and inter-day RSD < 7.72%), extraction recovery (70.96-80.78%) and stability under three different situations. Compared to water, the pharmacokinetic parameters clarified that ChCl-GL (1:2) could promote the absorption of SAB, the peak concentration (C-max) of 0.308 +/- 0.020 mg/L was slightly higher than 0.277 +/- 0.024 mg/L (SAB dissolved in water), and the peak time (T-max) was significantly decreased from 30 min (SAB dissolved in water) to 20 min. There was no significant difference on the metabolites between SAB dissolved in ChCI-GL (1:2) and in water. This is the first report on the pharmacokinetic study of DES as a candidate of drug carrier, and the results provide a meaningful basis for the application of DES in pharmaceutical preparation.